| Bioactivity | Pamicogrel (KBT3022) is a cyclooxygenase (COX) inhibitor. | ||||||||||||
| Invitro | Pamicogrel is a cyclooxygenase inhibitor with platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury[1]. | ||||||||||||
| Name | Pamicogrel | ||||||||||||
| CAS | 101001-34-7 | ||||||||||||
| Formula | C25H24N2O4S | ||||||||||||
| Molar Mass | 448.53 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Light P. Pamicogrel (Kanebo). IDrugs. 1999 Sep;2(9):938-42. |